Solid Malignant Neoplasm
📧 Sign up to get email alerts when something new happens for Solid Malignant Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE [NA]
This terminated University of Washington clinical trial tested technology-driven collaborative care for depression among cancer patients in …
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
A Mayo Clinic-led clinical trial validating DNA methylation markers for universal and site-specific cancer detection (NCT06304168) is curren…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer [Phase 2]
Phase 2 clinical trial evaluating cognitive behavioral therapy and multimodal therapy for sleep disturbance in cancer patients; results have…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating a rose geranium in sesame oil nasal spray for improving nasal vestibulitis symptoms in cancer patients u…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors [NA]
A completed Mayo Clinic trial evaluated virtual mindfulness and weight management to reduce relapse risk and improve wellbeing in cancer sur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2) [Phase 2]
A Phase 2 MATCH-subprotocol trial is evaluating trametinib for cancers with GNAQ or GNA11 mutations; the study is active/not recruiting and …
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F) [Phase 2]
Phase 2 MATCH subprotocol Z1F investigates copanlisib for cancers with PIK3CA mutations. Results (posted 2023-02-28) pertain to participants…
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A) [Phase 2]
Phase 2 MATCH subprotocol evaluates binimetinib as a targeted treatment for cancers with NRAS alterations; results were posted in 2021 and t…
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q) [Phase 2]
A Phase 2 MATCH-subprotocol Q trial evaluating ado-trastuzumab emtansine (T-DM1) for cancers with HER2 genetic changes; results were posted …